GEN Exclusives

More »

GEN News Highlights

More »
Jan 26, 2007

Aruna to Make Human Neural Cells from University of Georgia Available to Researchers

  • Aruna Biomedical will commercialize human neural progenitor cell technology developed at the University of Georgia Research Foundation.

    Under the terms of the technology licensing agreement, Aruna acquired the exclusive worldwide right to develop and commercialize neural cells derived from human embryonic stem cells. Aruna will offer the academic and industry research communities access to much sought after but never before available human neural cells, derived from human embryonic stem cells that relate to normal and diseased human conditions .

    Aruna anticipates launch of its first product, human neural progenitor (NP) cells, in early 2007 and add-on products will closely follow. The human NP cells will be sold and marketed through a third-party distribution partner and packaged as a kit with growth media and substrates.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

New Drugs for Ebola

Do you think that biopharma companies should not have to go through the normal drug approval process in order to get potential life-saving therapies to Ebola patients more quickly?